NRXS vs STT · rev $3.6M vs P/E 17, rev $7.84B
Neuraxis, Inc. (NRXS) versus State Street Corp (STT) — a side-by-side from cached financials, not a winner call.
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
State Street Corp (STT) is a asset management company listed on US.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
Latest reported STT revenue for 2026-06-30 was $7.84B. Net income was $1.85B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
NRXS currently screens at market cap $83.1M. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Not investment advice. Open the NRXS and STT stock pages for the full models.
Not investment advice.